Erkki Ruoslahti, president and CEO of the La Jolla Cancer Research Foundation, has been named the winner of the 1990 G.H.A. Clowes Memorial Award, given by the American Association for Cancer Research.

The award has been given annually since 1978 to recognize accomplishments in basic laboratory research. The $5,000 award was established by the Eli Lilly Co., an Indianapolis-based R&D company that focuses on medicine and agriculture, to honor Clowes, a founding member of AACR and former research director at Eli Lilly.

A native of Finland, Ruoslahti, 50, was cited for his discoveries and pioneering approach in the field of antibodies against tumors and the discovery of several proteins.

Ruoslahti is also an adjunct professor of pathology at the University of California, San Diego. His research has focused on halting cancer cells from invading other parts of the body, unlike existing cancer treatments, which kill cell tissue.

Another area that...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?